Table 3 Multivariable survival analysis with immune metagenes in the high proliferation tertile.
From: Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
PH(n= 657) | Multivariate | |
|---|---|---|
Variables | Hazard ratio (95% CI)2 | P- value3 |
Model 1 | ||
B/P (L, I, H)1 | 0.72 (0.58 to 0.89) | 0.003 |
T/NK (L, I, H) | 0.73 (0.59 to 0.90) | 0.003 |
Model 2 | ||
B/P (L, I, H) | 0.73 (0.62 to 0.89) | 0.002 |
M/D (L, I, H) | 0.70 (0.57 to 0.85) | 0.0004 |
Model 3 | ||
T/NK (L, I, H) | 0.77 (0.60 to 0.99) | 0.04 |
M/D (L, I, H) | 0.70 (0.55 to 0.90) | 0.006 |
Model 4 | ||
B/P (L, I, H) | 0.76 (0.61 to 0.94) | 0.01 |
M/D (L, I, H) | 0.75 (0.58 to 0.97) | 0.03 |
T/NK (L, I, H) | 0.88 (0.67 to 1.15) | 0.34 |